thiazoles has been researched along with Hyperlipoproteinemia Type II in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daida, H; Kashiwakura, Y; Kumon, H; Kusumi, N; Nasu, Y; Sawamura, T; Sumiyoshi, K; Takei, K; Watanabe, M; Yamada, H | 1 |
| Horikoshi, H; Ito, T; Shiomi, M; Tsujita, Y; Tsukada, T | 1 |
2 other study(ies) available for thiazoles and Hyperlipoproteinemia Type II
| Article | Year |
|---|---|
Dynamin-2 regulates oxidized low-density lipoprotein-induced apoptosis of vascular smooth muscle cell.
Topics: Animals; Apolipoproteins E; Apoptosis; Benzothiazoles; Coronary Vessels; Dynamin II; Endocytosis; Humans; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Receptors, LDL; Receptors, Oxidized LDL; Scavenger Receptors, Class E; Signal Transduction; Thiazoles; Toluene; Transfection; Tumor Suppressor Protein p53 | 2004 |
Combination treatment with troglitazone, an insulin action enhancer, and pravastatin, an inhibitor of HMG-CoA reductase, shows a synergistic effect on atherosclerosis of WHHL rabbits.
Topics: Animals; Aorta, Thoracic; Arteriosclerosis; Blood Glucose; Cholesterol, LDL; Chromans; Coronary Vessels; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Glucose Tolerance Test; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperinsulinism; Hyperlipoproteinemia Type II; Hypoglycemic Agents; Insulin Resistance; Male; Pravastatin; Rabbits; Thiazoles; Thiazolidinediones; Troglitazone; Xanthomatosis | 1999 |